S Cristina Oancea1, Vinay K Cheruvu2. 1. Department of Population Health, School of Medicine and Health Sciences, University of North Dakota, Room 2370 R, 501 North Columbia Road, Grand Forks, ND, 58202-9037, USA. cristina.oancea@med.und.edu. 2. Department of Biostatistics, Environmental Health Sciences, and Epidemiology, College of Public Health, Kent State University, Kent, OH, USA.
Abstract
PURPOSE: The goal of our study was to better understand the importance of adult cancer survivors (ACS) receiving Survivorship Care Plans (SCP) especially for their psychological well-being. We hypothesize that the receipt of SCP would decrease the likelihood of symptoms of current depression (SCD) in this population. METHODS: We tested our hypothesis by using a representative sample of ACS, more than 1 year from cancer diagnosis, who responded to the 2010 BRFSS survey. We used follow-up care instructions (FCI) and treatment summaries (TS) as a marker of SCP. Weighted multivariable logistic regression models were used to investigate the association between FCI and TS (individually and in combination) and SCD, among short-term (≤5 years from cancer diagnosis) and long-term (>5 years from cancer diagnosis) ACS. RESULTS: Out of 3191 final study participants, 32.8 % were short-term, and 67.2 % were long-term ACS. Among short-term ACS, the adjusted odds of SCD were 3 times higher (adjusted odds ratio (AOR) 3.14 [95%CI 1.29-7.65]) for those who did not receive TS + FCI than for those who received them both. Among long-term ACS, the adjusted odds of SCD were more than twice higher (AOR 2.18 [95%CI 1.14-4.19]) for those who received FCI and no TS compared to those who received them both. CONCLUSION: The present study results emphasize the importance of ACS receiving SCP. Adult cancer survivors may highly benefit from the receipt of SCP not only short-term but also long-term for their overall psychological well-being.
PURPOSE: The goal of our study was to better understand the importance of adult cancer survivors (ACS) receiving Survivorship Care Plans (SCP) especially for their psychological well-being. We hypothesize that the receipt of SCP would decrease the likelihood of symptoms of current depression (SCD) in this population. METHODS: We tested our hypothesis by using a representative sample of ACS, more than 1 year from cancer diagnosis, who responded to the 2010 BRFSS survey. We used follow-up care instructions (FCI) and treatment summaries (TS) as a marker of SCP. Weighted multivariable logistic regression models were used to investigate the association between FCI and TS (individually and in combination) and SCD, among short-term (≤5 years from cancer diagnosis) and long-term (>5 years from cancer diagnosis) ACS. RESULTS: Out of 3191 final study participants, 32.8 % were short-term, and 67.2 % were long-term ACS. Among short-term ACS, the adjusted odds of SCD were 3 times higher (adjusted odds ratio (AOR) 3.14 [95%CI 1.29-7.65]) for those who did not receive TS + FCI than for those who received them both. Among long-term ACS, the adjusted odds of SCD were more than twice higher (AOR 2.18 [95%CI 1.14-4.19]) for those who received FCI and no TS compared to those who received them both. CONCLUSION: The present study results emphasize the importance of ACS receiving SCP. Adult cancer survivors may highly benefit from the receipt of SCP not only short-term but also long-term for their overall psychological well-being.
Entities:
Keywords:
Cancer survivors; Depression; Follow-up care instructions; Survivorship care plan; Treatment summary
Authors: Jamie M Stagl; Michael H Antoni; Suzanne C Lechner; Laura C Bouchard; Bonnie B Blomberg; Stefan Glück; Robert P Derhagopian; Charles S Carver Journal: Health Psychol Date: 2014-07-28 Impact factor: 4.267
Authors: S Cristina Oancea; Tara M Brinkman; Kirsten K Ness; Kevin R Krull; Webb A Smith; D Kumar Srivastava; Leslie L Robison; Melissa M Hudson; James G Gurney Journal: J Cancer Surviv Date: 2014-01-24 Impact factor: 4.442
Authors: Kurt Kroenke; Tara W Strine; Robert L Spitzer; Janet B W Williams; Joyce T Berry; Ali H Mokdad Journal: J Affect Disord Date: 2008-08-27 Impact factor: 4.839
Authors: Lonnie K Zeltzer; Qian Lu; Wendy Leisenring; Jennie C I Tsao; Christopher Recklitis; Gregory Armstrong; Ann C Mertens; Leslie L Robison; Kirsten K Ness Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-02 Impact factor: 4.254
Authors: Sarah A Birken; Alecia S Clary; Shampa Bernstein; Jamiyla Bolton; Miriam Tardif-Douglin; Deborah K Mayer; Allison M Deal; Sara R Jacobs Journal: J Oncol Pract Date: 2018-07-13 Impact factor: 3.840
Authors: Brynn Fowler; Qian Ding; Lisa Pappas; Yelena P Wu; Lauri Linder; Jeff Yancey; Jennifer Wright; Margaret Clayton; Deanna Kepka; Anne C Kirchhoff Journal: J Cancer Educ Date: 2018-02 Impact factor: 2.037
Authors: Rebecca Selove; Maya Foster; Debra Wujcik; Maureen Sanderson; Pamela C Hull; David Shen-Miller; Steven Wolff; Debra Friedman Journal: Support Care Cancer Date: 2016-11-08 Impact factor: 3.603
Authors: David F Warner; Nicholas K Schiltz; Kurt C Stange; Charles W Given; Cynthia Owusu; Nathan A Berger; Siran M Koroukian Journal: Fam Med Community Health Date: 2017-07
Authors: Rebecca Selove; Sarah A Birken; Ted A Skolarus; Erin E Hahn; Anne Sales; Enola K Proctor Journal: J Clin Oncol Date: 2016-09-30 Impact factor: 44.544
Authors: Joseph L Benci; Carolyn C Vachani; Margaret K Hampshire; Christina Bach; Karen Arnold-Korzeniowski; James M Metz; Christine E Hill-Kayser Journal: Front Oncol Date: 2020-01-31 Impact factor: 6.244